Potent activation of the human tandem pore domain K channel TRESK with clinical concentrations of volatile anesthetics

Anesth Analg. 2004 Dec;99(6):1715-1722. doi: 10.1213/01.ANE.0000136849.07384.44.

Abstract

The tandem pore domain K channel family mediates background K currents present in excitable cells. Currents passed by certain members of the family are enhanced by volatile anesthetics, thus suggesting a novel mechanism of anesthesia. The newest member of the family, termed TRESK (TWIK [tandem pore domain weak inward rectifying channel]-related spinal cord K channel), has not been studied for anesthetic sensitivity. We isolated the coding sequence for TRESK from human spinal cord RNA and functionally expressed it in Xenopus oocytes and transfected COS-7 cells. With both whole-cell voltage-clamp and patch-clamp recording, TRESK currents increased up to three-fold by clinical concentrations of isoflurane, halothane, sevoflurane, and desflurane. Nonanesthetics (nonimmobilizers) had no effect on TRESK. Various IV anesthetics, including etomidate, thiopental, and propofol, have a minimal effect on TRESK currents. Amide and ester local anesthetics inhibit TRESK in a concentration-dependent manner but at concentrations generally larger than those that inhibit other tandem pore domain K channels. We also determined that TRESK is found not only in spinal cord, but also in human brain RNA. These results identify TRESK as a target of volatile anesthetics and suggest a role for this background K channel in mediating the effects of inhaled anesthetics in the central nervous system.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anesthetics, Inhalation / pharmacology*
  • Anesthetics, Intravenous / pharmacology
  • Anesthetics, Local / pharmacology
  • Animals
  • COS Cells
  • Chlorocebus aethiops
  • Glyceraldehyde-3-Phosphate Dehydrogenases / metabolism
  • Humans
  • Membrane Potentials / drug effects
  • Oligonucleotides / pharmacology
  • Oocytes / metabolism
  • Patch-Clamp Techniques
  • Potassium Channels / agonists*
  • Potassium Channels / genetics
  • Potassium Channels, Tandem Pore Domain / biosynthesis
  • Potassium Channels, Tandem Pore Domain / drug effects
  • Potassium Channels, Tandem Pore Domain / genetics
  • RNA, Complementary / biosynthesis
  • RNA, Complementary / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Spinal Cord / metabolism
  • Xenopus laevis

Substances

  • Anesthetics, Inhalation
  • Anesthetics, Intravenous
  • Anesthetics, Local
  • KCNK18 protein, human
  • KCNK5 protein, human
  • Oligonucleotides
  • Potassium Channels
  • Potassium Channels, Tandem Pore Domain
  • RNA, Complementary
  • Glyceraldehyde-3-Phosphate Dehydrogenases